logo
Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI
A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer Disease
Mid-life Cardiovascular Risk Impacts Memory Function : The Framingham Offspring Study
Distinct Patterns and Clinical Implications of Semantic Memory Deterioration Among Patients With MCI
Memory Profiles in Pathology or Biomarker Confirmed Alzheimer Disease and Frontotemporal Dementia
Subtype of Mild Cognitive Impairment in Elderly Patients With Essential Tremor
Effectiveness of a Fotonovela for Reducing Depression and Stress in Latino Dementia Family Caregivers
How Preserved is Emotion Recognition in Alzheimer Disease Compared With Behavioral Variant Frontotemporal Dementia?
The Dementia Severity Rating Scale Predicts Clinical Dementia Rating Sum of Boxes Scores
Divergent Processing of Monetary and Social Reward in Behavioral Variant Frontotemporal Dementia and Alzheimer Disease
Mortality and Productivity Losses From Alzheimer Disease Among US Adults Aged 40 to 64 Years, 1999 to 2010
Reelin Signaling Pathway Genotypes and Alzheimer Disease in a Spanish Population
Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-Old
Cancer and Dementia : It’s Complicated